Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Mirikizumab in Crohn Disease: NCT07292012 Clinical Landscape Report 2026
16 October 2026
NCT07292012 clinical landscape for Crohn Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ipilimumab in Unresectable Hepatocellular Carcinoma: NCT07291076 Clinical Landscape Report 2026
16 October 2026
NCT07291076 clinical landscape for Unresectable Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Menthol in Sleep Initiation and Maintenance Disorders: NCT07294469 Clinical Landscape Report 2026
16 October 2026
NCT07294469 clinical landscape for Sleep Initiation and Maintenance Disorders: endpoints, sponsor, phase, geography, readouts, asset context and development…
9 min read
Atezolizumab in Locally Advanced Hepatocellular Carcinoma: NCT07293468 Clinical Landscape Report 2026
16 October 2026
NCT07293468 clinical landscape for Locally Advanced Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development w…
9 min read
Lenvatinib mesylate in Advanced Hepatocellular Carcinoma: NCT07297654 Clinical Landscape Report 2026
16 October 2026
NCT07297654 clinical landscape for Advanced Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
QX030N in Inflammatory Bowel Diseases: ACTRN12625001454460 Clinical Landscape Report 2026
16 October 2026
ACTRN12625001454460 clinical landscape for Inflammatory Bowel Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
9 min read
Infliximab in Colitis, Ulcerative: NCT07297069 Clinical Landscape Report 2026
16 October 2026
NCT07297069 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HRS-4642 in Pancreatic Ductal Adenocarcinoma: NCT07296341 Clinical Landscape Report 2026
16 October 2026
NCT07296341 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Modafinil in Fatigue: NCT07295834 Clinical Landscape Report 2026
16 October 2026
NCT07295834 clinical landscape for Fatigue: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
MH-002 in Colitis, Ulcerative: NCT07296315 Clinical Landscape Report 2026
16 October 2026
NCT07296315 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pelareorep in Advanced Hepatocellular Carcinoma: NCT07300488 Clinical Landscape Report 2026
16 October 2026
NCT07300488 clinical landscape for Advanced Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
Budesonide/Formoterol fumarate/Glycopyrronium Bromide in Pulmonary Disease, Chronic Obstructive: CTRI/2025/12/099667 Clinical Landscape Report 2026
16 October 2026
CTRI/2025/12/099667 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and developm…